Hypothesis

Syncing 48‑hour fasts to the circadian nadir of mTORC1 activity amplifies mitochondrial NAD⁺ salvage and SIRT3‑mediated deacetylation, producing a synergistic boost in oxidative capacity beyond that seen with intermittent fasting alone.

Mechanistic Rationale

Intermittent fasting (IF) raises AMPK and SIRT1, suppresses mTORC1, and induces ketosis, which together enhance mitochondrial biogenesis and mitophagy[1][2]. A 48‑hour fast doubles autophagy and quintuples growth hormone, while quadrupling β‑hydroxybutyrate (BHB) that acts as an HDAC inhibitor and efficient fuel[3]. Proteomic work shows IF drives tissue‑specific remodeling in liver, muscle and brain[4].

We propose that the cellular response to a prolonged fast is gated by the circadian clock: mTORC1 activity reaches its lowest point during the early subjective night (around ZT14‑ZT18 in humans). Fasting at this nadir removes residual mTORC1 inhibition, allowing a maximal AMPK/SIRT1 activation wave. The resulting NAD⁺ surge fuels both SIRT1 and the mitochondrial sirtuin SIRT3, which deacetylates key Complex I subunits (NDUFA9, NDUFS1) and stimulates fatty‑acid oxidation[5]. Concurrently, elevated BHB inhibits HDACs, increasing FOXO3a‑driven expression of antioxidant enzymes (SOD2, CAT) that protect newly remodeled mitochondria from ROS‑induced damage.

Thus, the timing of the 48‑hour fast creates a double hit: (1) metabolic stress that maximally elevates NAD⁺/NADH ratio, and (2) epigenetic remodeling that sustains antioxidant capacity, together yielding a greater increase in mitochondrial respiratory capacity and mitophagic flux than IF or untimed prolonged fasting alone.

Predictions & Experimental Design

1. Primary outcome – Mitochondrial oxidative phosphorylation (OXPHOS) capacity measured by high‑resolution respirometry in percutaneous vastus lateralis biopsies will be ≥20 % higher after a 4‑week regimen of IF (16:8) plus a 48‑hour fast timed to the individual’s melatonin onset (≈02:00‑04:00 h) compared with the same regimen where the 48‑hour fast is placed at a random daytime interval.
2. Secondary outcomes – (a) Muscle NAD⁺/NADH ratio ↑≥15 %; (b) Acetylation of mitochondrial Complex I subunits ↓≥30 % (Western blot with acetyl‑lysine antibody); (c) FOXO3a target gene expression (SOD2, CAT) ↑≥2‑fold; (d) Circulating BHB ≥4 mM during the fast; (e) No increase in fatigue or sleep disturbance scores beyond those reported for untimed 48‑hour fasts[6].

Design – Randomized, crossover trial in 30 healthy overweight adults (BMI 25‑30). Each participant completes two 4‑week arms separated by a 4‑week washout. Arm A: IF 16:8 daily + one 48‑hour fast scheduled 30 min after melatonin onset (determined via salivary melatonin). Arm B: same IF + 48‑hour fast at a fixed clock time (e.g., 10:00‑12:00) irrespective of melatonin. Compliance verified by continuous glucose monitoring and ketone strips. Outcomes measured before and after each arm.

Potential Implications

If confirmed, this hypothesis would define a chronobiological prescription for fasting that maximizes mitochondrial hormesis without additional caloric restriction, offering a low‑cost strategy to combat age‑related mitochondrial decline and metabolic disease. It also explains why some individuals report outsized benefits from occasional long fasts: they may be inadvertently aligning with their internal nadir of mTORC1 activity.